Epigenetic Reprogramming in Relapse/Refractory AML
Clinical trial NCT03263936 · COMPLETED
Trial details
- NCT number
- NCT03263936
- Sponsor
- Therapeutic Advances in Childhood Leukemia Consortium
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2020-07-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.